mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC

Clinical trial NCT06791512 · RECRUITING

Trial details

NCT number: NCT06791512
Sponsor: Jun Huang
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer (CRC)pMMR/MSS Adenocarcinoma of the Colon or Rectum

Start date: 2025-01-18
Primary completion: 2030-12-31
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.